A non-inferiority study to compare daily fast-acting insulin versus twice a week slow-acting insulin–moderate diabetes mode

Abstract Purpose Given the high prevalence of diabetes (D), several animal models have been analyzed. In the literature, most of the animal models have studied severe D. However, in clinical practice, most patients have moderate disease. Therefore, the present study aimed to describe a moderate D...

Full description

Bibliographic Details
Main Authors: Cristina Pires Camargo, Rafael Hori Nagamine Weschenfelder, Guilherme Moreira da Fonseca, Alexandre Agostinho da Cruz Sousa, Rolf Gemperli
Format: Article
Language:English
Published: Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia 2020-08-01
Series:Acta Cirúrgica Brasileira
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502020000700201&tlng=en
_version_ 1818491305411477504
author Cristina Pires Camargo
Rafael Hori Nagamine Weschenfelder
Guilherme Moreira da Fonseca
Alexandre Agostinho da Cruz Sousa
Rolf Gemperli
author_facet Cristina Pires Camargo
Rafael Hori Nagamine Weschenfelder
Guilherme Moreira da Fonseca
Alexandre Agostinho da Cruz Sousa
Rolf Gemperli
author_sort Cristina Pires Camargo
collection DOAJ
description Abstract Purpose Given the high prevalence of diabetes (D), several animal models have been analyzed. In the literature, most of the animal models have studied severe D. However, in clinical practice, most patients have moderate disease. Therefore, the present study aimed to describe a moderate D condition. Methods We analyzed 20 Wistar rats, age eight-weeks, weight between 200g-250g. All animals received an intravenous injection of Streptozotocin (55mg/kg weight). On the 15th day after D induction, the animals were divided into two groups: Group I – animals receiving a single daily dose of fast-acting insulin (FAIG) NPH (1UI,SC) for partial glycemic control, and Group II - animals receiving slow-acting insulin(SAIG) twice a week. We measured glycemia, weight, and adverse events every week during two months. Results Of the total of animals analyzed in the study, three animals died in the FAIG and two animals died in the SAIG. Regarding the glycemic level, results were 339.5 ± 125.4mg/dL (95CI 302.3402 to 376.6842) in the FAIG, and 367.8 ± 66.1mg/dL (95IC 333.7607 to 401.8978) in the SAIG. There was no difference between groups as to weight during the study. Conclusion The use of slow-acting-insulin is not inferior to the use of fast-acting-insulin in the management of partially insulin-controlled moderate diabetes in rats.
first_indexed 2024-12-10T17:29:04Z
format Article
id doaj.art-c5cb3008838a4fb09550a1729c3d26a5
institution Directory Open Access Journal
issn 0102-8650
language English
last_indexed 2024-12-10T17:29:04Z
publishDate 2020-08-01
publisher Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia
record_format Article
series Acta Cirúrgica Brasileira
spelling doaj.art-c5cb3008838a4fb09550a1729c3d26a52022-12-22T01:39:44ZengSociedade Brasileira para o Desenvolvimento da Pesquisa em CirurgiaActa Cirúrgica Brasileira0102-86502020-08-0135710.1590/s0102-865020200070000004A non-inferiority study to compare daily fast-acting insulin versus twice a week slow-acting insulin–moderate diabetes modeCristina Pires Camargohttps://orcid.org/0000-0002-3134-0003Rafael Hori Nagamine Weschenfelderhttps://orcid.org/0000-0001-8747-6658Guilherme Moreira da Fonsecahttps://orcid.org/0000-0001-8198-415XAlexandre Agostinho da Cruz Sousahttps://orcid.org/0000-0003-3844-9973Rolf Gemperlihttps://orcid.org/0000-0001-9913-6079Abstract Purpose Given the high prevalence of diabetes (D), several animal models have been analyzed. In the literature, most of the animal models have studied severe D. However, in clinical practice, most patients have moderate disease. Therefore, the present study aimed to describe a moderate D condition. Methods We analyzed 20 Wistar rats, age eight-weeks, weight between 200g-250g. All animals received an intravenous injection of Streptozotocin (55mg/kg weight). On the 15th day after D induction, the animals were divided into two groups: Group I – animals receiving a single daily dose of fast-acting insulin (FAIG) NPH (1UI,SC) for partial glycemic control, and Group II - animals receiving slow-acting insulin(SAIG) twice a week. We measured glycemia, weight, and adverse events every week during two months. Results Of the total of animals analyzed in the study, three animals died in the FAIG and two animals died in the SAIG. Regarding the glycemic level, results were 339.5 ± 125.4mg/dL (95CI 302.3402 to 376.6842) in the FAIG, and 367.8 ± 66.1mg/dL (95IC 333.7607 to 401.8978) in the SAIG. There was no difference between groups as to weight during the study. Conclusion The use of slow-acting-insulin is not inferior to the use of fast-acting-insulin in the management of partially insulin-controlled moderate diabetes in rats.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502020000700201&tlng=enDiabetes mellitusInsulinRats
spellingShingle Cristina Pires Camargo
Rafael Hori Nagamine Weschenfelder
Guilherme Moreira da Fonseca
Alexandre Agostinho da Cruz Sousa
Rolf Gemperli
A non-inferiority study to compare daily fast-acting insulin versus twice a week slow-acting insulin–moderate diabetes mode
Acta Cirúrgica Brasileira
Diabetes mellitus
Insulin
Rats
title A non-inferiority study to compare daily fast-acting insulin versus twice a week slow-acting insulin–moderate diabetes mode
title_full A non-inferiority study to compare daily fast-acting insulin versus twice a week slow-acting insulin–moderate diabetes mode
title_fullStr A non-inferiority study to compare daily fast-acting insulin versus twice a week slow-acting insulin–moderate diabetes mode
title_full_unstemmed A non-inferiority study to compare daily fast-acting insulin versus twice a week slow-acting insulin–moderate diabetes mode
title_short A non-inferiority study to compare daily fast-acting insulin versus twice a week slow-acting insulin–moderate diabetes mode
title_sort non inferiority study to compare daily fast acting insulin versus twice a week slow acting insulin moderate diabetes mode
topic Diabetes mellitus
Insulin
Rats
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502020000700201&tlng=en
work_keys_str_mv AT cristinapirescamargo anoninferioritystudytocomparedailyfastactinginsulinversustwiceaweekslowactinginsulinmoderatediabetesmode
AT rafaelhorinagamineweschenfelder anoninferioritystudytocomparedailyfastactinginsulinversustwiceaweekslowactinginsulinmoderatediabetesmode
AT guilhermemoreiradafonseca anoninferioritystudytocomparedailyfastactinginsulinversustwiceaweekslowactinginsulinmoderatediabetesmode
AT alexandreagostinhodacruzsousa anoninferioritystudytocomparedailyfastactinginsulinversustwiceaweekslowactinginsulinmoderatediabetesmode
AT rolfgemperli anoninferioritystudytocomparedailyfastactinginsulinversustwiceaweekslowactinginsulinmoderatediabetesmode
AT cristinapirescamargo noninferioritystudytocomparedailyfastactinginsulinversustwiceaweekslowactinginsulinmoderatediabetesmode
AT rafaelhorinagamineweschenfelder noninferioritystudytocomparedailyfastactinginsulinversustwiceaweekslowactinginsulinmoderatediabetesmode
AT guilhermemoreiradafonseca noninferioritystudytocomparedailyfastactinginsulinversustwiceaweekslowactinginsulinmoderatediabetesmode
AT alexandreagostinhodacruzsousa noninferioritystudytocomparedailyfastactinginsulinversustwiceaweekslowactinginsulinmoderatediabetesmode
AT rolfgemperli noninferioritystudytocomparedailyfastactinginsulinversustwiceaweekslowactinginsulinmoderatediabetesmode